Market Price

281.42 

2.92 1.1%

as of Oct 23 '20

52 Week Range:

119.01 319.19


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; and Impella Connect, a cloud-based technology that enables secure, cloud-based, and remote viewing of the Automated Impella Controller for physicians and hospital staffs. In addition, the company engages in the development of Impella XR Sheath, a sheath designed to expand and recoil to all for ease of use upon insertion of an Impella heart pump and minimize the size of the arteriotomy; Impella BTR, a percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20
Equity (BVPS) 2.88
2.78
3.00
3.52
4.02
4.73
8.11
9.56
14.25
18.87
23.26
growth rate -3.5% 7.9% 17.3% 14.2% 17.7% 71.5% 17.9% 49.1% 32.4% 23.3%
Earnings BIT -18.35
-10.86
2.54
16.86
8.53
29.18
66.16
91.73
158.47
223.90
248.64
growth rate 0.0% 100.0% 563.8% -49.4% 242.0% 126.8% 38.7% 72.8% 41.3% 11.1%
Avg.PE -16.10
-33.70
588.24
51.02
147.06
22.54
32.13
118.45
197.83
56.52
46.60
growth rate 0.0% 100.0% -91.3% 188.2% -84.7% 42.6% 268.7% 67.0% -71.4% -17.6%
ROA -14.33
-9.00
1.05
9.27
3.92
41.81
10.01
10.70
16.78
28.14
17.88
growth rate 0.0% 100.0% 782.9% -57.7% 966.6% -76.1% 6.9% 56.8% 67.7% -36.5%
ROE -16.99
-11.05
1.29
11.40
4.81
49.44
11.55
12.70
19.65
31.85
20.28
growth rate 0.0% 100.0% 783.7% -57.8% 927.9% -76.6% 10.0% 54.7% 62.1% -36.3%
ROIC -16.99
-11.05
1.29
11.40
4.81
49.44
11.55
12.21
19.39
31.85
20.28
growth rate 0.0% 100.0% 783.7% -57.8% 927.9% -76.6% 5.7% 58.8% 64.3% -36.3%
Cur. Ratio 4.58
3.79
4.93
4.31
3.88
5.60
6.20
4.70
5.84
6.39
4.82
growth rate -17.3% 30.1% -12.6% -10.0% 44.3% 10.7% -24.2% 24.3% 9.4% -24.6%
Quick Ratio 3.97
3.39
4.36
3.68
3.32
4.17
5.48
4.08
5.10
5.50
4.00
growth rate -14.6% 28.6% -15.6% -9.8% 25.6% 31.4% -25.6% 25.0% 7.8% -27.3%
Leverage 1.20
1.26
1.22
1.24
1.22
1.16
1.15
1.22
1.14
1.13
1.14
growth rate 5.0% -3.2% 1.6% -1.6% -4.9% -0.9% 6.1% -6.6% -0.9% 0.9%
Balance Sheet Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20
Acct.Receivable 13.50
15.40
20.46
22.95
24.36
31.83
42.82
54.06
70.01
90.81
84.65
growth rate 14.1% 32.8% 12.2% 6.2% 30.7% 34.5% 26.2% 29.5% 29.7% -6.8%
Acct.Payable 19.39
22.86
25.65
10.39
9.38
20.62
23.57
32.19
32.77
growth rate 17.9% 12.2% -59.5% -9.7% 119.8% 14.3% 36.6% 1.8%
Cur.Assets 82.70
84.70
110.54
116.61
117.97
185.04
288.39
326.96
494.27
677.20
635.86
growth rate 2.4% 30.5% 5.5% 1.2% 56.9% 55.9% 13.4% 51.2% 37.0% -6.1%
Total Assets 129.60
131.60
153.91
170.00
205.41
338.37
423.93
550.41
786.38
1,054.35
1,216.46
growth rate 1.5% 17.0% 10.5% 20.8% 64.7% 25.3% 29.8% 42.9% 34.1% 15.4%
Cash 4.80
5.80
5.99
9.45
20.92
22.40
48.23
39.04
42.98
121.02
192.34
growth rate 20.8% 3.3% 57.8% 121.3% 7.1% 115.3% -19.1% 10.1% 181.6% 58.9%
Inventory 9.20
7.50
11.14
14.93
13.95
16.77
26.74
34.93
50.20
80.94
90.09
growth rate -18.5% 48.6% 34.0% -6.6% 20.3% 59.4% 30.6% 43.7% 61.2% 11.3%
Cur.Liabilities 18.10
22.30
22.42
27.06
30.41
39.32
46.54
69.62
84.68
106.00
131.89
growth rate 23.2% 0.5% 20.7% 12.4% 29.3% 18.4% 49.6% 21.6% 25.2% 24.4%
Liabilities 21.60
26.80
27.61
32.92
37.05
46.81
55.16
98.34
96.85
117.46
151.00
growth rate 24.1% 3.0% 19.2% 12.6% 26.3% 17.8% 78.3% -1.5% 21.3% 28.6%
LT Debt 0.00
0.00
0.00
0.00
15.54
15.54
15.54
growth rate 0.0% 0.0%
Equity 108.00
104.70
126.30
137.08
168.35
291.56
368.78
452.07
689.52
936.89
1,065.47
growth rate -3.1% 20.6% 8.5% 22.8% 73.2% 26.5% 22.6% 52.5% 35.9% 13.7%
Common Shares 37.00
37.00
40.00
41.00
42.00
43.00
45.00
45.00
46.00
46.00
46.00
growth rate 0.0% 8.1% 2.5% 2.4% 2.4% 4.7% 0.0% 2.2% 0.0% 0.0%
Cash Flow Statement Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20
Capital Expenditures 1.80
1.80
1.75
2.84
2.76
5.19
15.62
50.42
55.86
44.00
44.01
growth rate 0.0% -3.1% 62.5% -2.6% 87.9% 201.2% 222.7% 10.8% -21.2% 0.0%
Cash Dividends 0.00 0.00 0.00 0.00
growth rate
Cash From OA -7.36
1.60
3.63
26.40
23.47
43.29
76.80
115.12
192.55
252.20
314.92
growth rate 100.0% 127.1% 626.4% -11.1% 84.5% 77.4% 49.9% 67.3% 31.0% 24.9%
FCF per Share -0.25
-0.01
-0.10
0.52
0.44
0.76
1.38
1.54
2.26
4.14
5.58
growth rate 0.0% 0.0% 100.0% -15.4% 72.7% 81.6% 11.6% 46.8% 83.2% 34.8%
Sale Purchase of Stock 14.68
-11.55
10.06
11.72
10.91
12.38
11.70
growth rate -100.0% 100.0% 16.6% -7.0% 13.5% -5.5%
FCF -9.00
-0.20
2.00
24.00
21.00
38.00
61.00
65.00
137.00
208.00
271.00
growth rate 0.0% 100.0% 1,100.0% -12.5% 81.0% 60.5% 6.6% 110.8% 51.8% 30.3%
Income Statement Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20
Sales 85.70
101.20
126.38
158.12
183.64
230.31
329.54
445.30
593.75
769.43
840.88
growth rate 18.1% 24.9% 25.1% 16.1% 25.4% 43.1% 35.1% 33.3% 29.6% 9.3%
Op.Income -25.10
-11.20
1.50
15.01
8.36
29.18
66.16
91.73
158.47
223.90
248.64
growth rate 0.0% 100.0% 904.3% -44.3% 248.9% 126.8% 38.7% 72.8% 41.3% 11.1%
IBT -18.40
-10.90
2.54
16.86
8.53
28.77
65.84
91.34
160.44
263.36
256.83
growth rate 0.0% 100.0% 563.1% -49.4% 237.2% 128.9% 38.7% 75.6% 64.2% -2.5%
Net Income -19.00
-11.80
1.50
15.01
7.35
113.69
38.15
52.12
112.17
259.02
203.01
growth rate 0.0% 100.0% 904.3% -51.0% 1,446.6% -66.5% 36.6% 115.2% 130.9% -21.6%
EPS -0.52
-0.32
0.04
0.37
0.18
2.65
0.85
1.17
2.45
5.61
4.43
growth rate 0.0% 100.0% 825.0% -51.4% 1,372.2% -67.9% 37.7% 109.4% 129.0% -21.0%
Gross Profit 63.20
79.20
101.87
126.53
146.32
190.37
279.12
374.68
495.17
639.87
689.58
growth rate 25.3% 28.6% 24.2% 15.6% 30.1% 46.6% 34.2% 32.2% 29.2% 7.8%
R&D 26.00
26.70
27.16
25.65
30.71
35.46
48.71
64.80
73.96
94.42
99.33
growth rate 2.7% 1.7% -5.6% 19.7% 15.5% 37.3% 33.0% 14.1% 27.7% 5.2%

Quarterly Statements

Item Name Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Earnings BIT 61.08
60.49
70.46
56.61
35.77
growth rate -1.0% 16.5% -19.7% -36.8%
Balance Sheet Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Acct.Receivable 86.21
94.32
100.99
84.65
82.08
growth rate 9.4% 7.1% -16.2% -3.0%
Acct.Payable 29.69
31.74
31.57
32.77
27.75
growth rate 6.9% -0.5% 3.8% -15.3%
Cur.Assets 677.37
647.43
636.58
635.86
619.69
growth rate -4.4% -1.7% -0.1% -2.5%
Total Assets 1,125.06
1,124.35
1,196.61
1,216.46
1,249.51
growth rate -0.1% 6.4% 1.7% 2.7%
Cash 101.05
150.28
117.97
192.34
214.83
growth rate 48.7% -21.5% 63.0% 11.7%
Inventory 87.73
90.30
91.19
90.09
89.28
growth rate 2.9% 1.0% -1.2% -0.9%
Cur.Liabilities 100.20
112.23
126.26
131.89
110.38
growth rate 12.0% 12.5% 4.5% -16.3%
Liabilities 122.47
132.89
149.75
151.00
147.66
growth rate 8.5% 12.7% 0.8% -2.2%
LT Debt
growth rate
Equity 1,002.59
991.46
1,046.86
1,065.47
1,101.85
growth rate -1.1% 5.6% 1.8% 3.4%
Common Shares 0.45
0.45
0.45
0.45
0.45
growth rate -0.4% -0.2% 0.0% -0.2%
Cash Flow Statement Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Capital Expenditures 12.25
12.36
8.85
10.55
10.04
growth rate 0.9% -28.4% 19.1% -4.8%
Cash Dividends
growth rate
Cash From OA 64.63
74.26
89.44
86.59
31.76
growth rate 14.9% 20.4% -3.2% -63.3%
Sale Purchase of Stock
growth rate
FCF 52.38
61.90
80.59
76.05
21.72
growth rate 18.2% 30.2% -5.6% -71.5%
Income Statement Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Sales 207.67
204.97
221.58
206.66
164.85
growth rate -1.3% 8.1% -6.7% -20.2%
Op.Income 61.08
60.49
70.46
56.61
35.77
growth rate -1.0% 16.5% -19.7% -36.8%
IBT 103.14
17.36
97.02
39.31
61.08
growth rate -83.2% 458.9% -59.5% 55.4%
Net Income 88.92
13.07
69.22
31.80
44.59
growth rate -85.3% 429.6% -54.1% 40.2%
EPS
growth rate
Gross Profit 170.59
170.11
181.59
167.29
128.87
growth rate -0.3% 6.8% -7.9% -23.0%
R&D 23.43
23.66
25.45
26.79
25.56
growth rate 1.0% 7.6% 5.3% -4.6%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A (88.63)

YOY Growth Grade:

B (72.01)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 82.49 81.03 54.16
EPS / Growth 60.4% 3.47 24.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 28.7%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 24.0% 26.3% 26.3%
Future PE 48.00 63.11 63.11
Future EPS 29.85 35.98 35.98
Value Price
MOS %
354.15
25.8%
561.33
99.5%
561.33
99.5%
MOS Price 177.07 280.67 280.67
IRT 13.08 12.31 12.31

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.